Actinium Pharmaceuticals
ATNM
$9.69
Share price
-1.12%
Change (1 day)
8.27%
Change (1 year)
Categories
Actinium Pharmaceuticals (ATNM) - P/B ratio
P/B ratio as of May 2024 : 6.66
According to Actinium Pharmaceuticals's latest financial reports the company has a price-to-book ratio of 6.66.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Actinium Pharmaceuticals - P/B ratio (from 2011 to 2024)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2024-12-31 | N/A | -100% |
| 2023-12-31 | 3.83 | -6.23% |
| 2022-12-31 | 4.08 | 125.6% |
| 2021-12-31 | 1.81 | -18.86% |
| 2020-12-31 | 2.23 | -64.89% |
| 2019-12-31 | 6.35 | 25.03% |
| 2018-12-31 | 5.08 | 30.8% |
| 2017-12-31 | 3.88 | 43.41% |
| 2016-12-31 | 2.71 | -58.18% |
| 2015-12-31 | 6.48 | -107.05% |
| 2014-12-31 | -91.8 | -1.03% |
| 2013-12-31 | -92.8 | -431.25% |
| 2012-12-31 | 28.0 | |
| 2011-12-31 | N/A | |
| 2010-12-31 | N/A | |
| 2009-12-31 | N/A | |
| 2008-12-31 | N/A | |
| 2007-12-31 | N/A | |
| 2006-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Genocea Biosciences
GNCA | 0.0005 | -99.99% | 🇺🇸 USA |
 Amicus Therapeutics
FOLD | 18.0 | 170.91% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | 2.88 | -56.67% | 🇺🇸 USA |